Michael Hien Bien, MD
Internal Medicine · San Dimas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
- Since medical school
- 22 years
- Irvine California College of Medicine, 2004
Offices
6 locations · California Kidney Specialists · Cua, Gan and Bien Medical Corporation · Cua and Gan Medical Corporation
Hospitals listed: 552552 · 552816 · 552837 · Casa Colina Hospital · Chino Valley Medical Center · Montclair Hospital Medical Center · Pomona Valley Hospital Medical Center · San Antonio Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bien’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A74264 · Current
Licensed to practise in California · since 2001 · expires 2028-07-31 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Nephrology
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Casa Colina HospitalPomona, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency department79% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Chino Valley Medical CenterChino, CAAcute Care Hospital · Proprietary · Has an emergency departmentPart of Prime Healthcare Services, which runs 45 hospitals in 14 statesPatients rate it 2 of 5 · 61% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.258, Oct 2024 – Sep 2025
- Montclair Hospital Medical CenterMontclair, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Prime Healthcare Services, which runs 45 hospitals in 14 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Pomona Valley Hospital Medical CenterPomona, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Pomona Valley Hospital Medical CenterPatients rate it 2 of 5 · 68% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.64 (0.33 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.398, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.389, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.155, Oct 2024 – Sep 2025
- San Antonio Regional HospitalUpland, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of San Antonio Regional HospitalPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
See every measure and the patient survey for Casa Colina Hospital
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 5 the same, 0 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.08) · 111 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.43 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 29 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 221 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 429 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 432 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.22 (0.68 to 5.75) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.58 (0 to 3.27) · 153 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.52 (0.83 to 4.21) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.92 (0 to 15.66) · 148 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.74 (1.56 to 9.92) · 123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.76 (0.23 to 3.28) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.47 (0 to 1.63) · 334 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 26 cases | None | Apr 2023 – Mar 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -53.5 · 29 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 39 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.3 to 16.6) · 359 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 173 cases | No different | Jan 2024 – Dec 2024 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 71% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 83% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Chino Valley Medical Center
Behind the star rating — Deaths: 1 better, 2 the same, 0 worse of 3 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.258 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.1) · 201 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.44 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 62 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.6 · 38 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 966 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,420 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,449 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.27 (0.72 to 5.83) · 106 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (0.57 to 4) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.31 (0 to 1.27) · 921 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 40 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.7 · 167 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.3 · 71 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 53.4 · 160 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 296 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 43 cases | None | Jul 2023 – Jun 2025 |
What patients said (428 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 80% |
| Yes, staff "did" give patients information about help after discharge | 75% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 76% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 77% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Montclair Hospital Medical Center
Behind the star rating — Deaths: 1 better, 1 the same, 0 worse of 2 measures. Safety: 1 better, 3 the same, 0 worse of 4 measures. Readmissions: 0 better, 3 the same, 1 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 114 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.46 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 11.1 · 137 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 549 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,034 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,045 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (0.8 to 6.02) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 46 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 775 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.036 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.263 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 48 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 62.2 · 140 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 216 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.4 to 17.4) · 46 cases | No different | Jan 2022 – Dec 2024 |
What patients said (437 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 1 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 67% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 49% |
| Yes, staff "did" give patients this information | 76% |
| Yes, staff "did" give patients information about help after discharge | 70% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 74% |
| Patients who gave a rating of "9" or "10" (high) | 56% |
| Staff "always" explained new medications | 65% |
| Nurses "always" explained things so they could understand | 64% |
| Nurses "always" listened carefully | 60% |
| Nurses "always" treated them with courtesy and respect | 76% |
| "Always" quiet at night | 34% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 32% |
| Yes, staff "did" give patients information about possible symptoms | 81% |
See every measure and the patient survey for Pomona Valley Hospital Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.64 (0.33 to 0.96) | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.398 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.389 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.155 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.84) · 1,069 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 169.52 (120.62 to 218.41) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.7 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.2 · 369 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.5 · 190 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.7 · 583 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 5,235 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.42) · 5,161 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.2 (1.1 to 5.3) · 996 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.55 (0 to 3.22) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.88 (0.32 to 3.44) · 911 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.99 (0 to 12.42) · 189 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.25 (0.34 to 8.16) · 172 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 196 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.1 (0 to 0.65) · 4,157 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 64 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.953 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.438 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 278 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 982 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.1 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -51.4 · 454 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -29.1 · 219 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 453 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 7.6) · 74 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.3 (9.5 to 18.1) · 74 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 57 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.9 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 137 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.1 to 18) · 319 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 199 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,021 patients answered, 13% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for San Antonio Regional Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.42 (0.49 to 2.35) · 1,107 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.8 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.04 (110.22 to 223.86) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.4 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 305 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.7 · 499 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 16.7 · 398 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5 · 3,795 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 5,607 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,828 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.55 (3.37 to 7.73) · 1,096 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.31 (0 to 2.85) · 315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.27 to 4.28) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.26 (8.83 to 21.68) · 347 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.6 (0.86 to 8.34) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 331 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.35 (0 to 1.03) · 4,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 37 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.9 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.73 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.873 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 405 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 820 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.2 · 177 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 11 · 349 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.5 · 536 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 970 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 35 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.2 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 179 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12 (9 to 16.1) · 285 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 234 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,938 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 51% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 36% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$386,757
Medicare paid this office $386,757 for 430 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 105 | $196,185 | $299 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 88 | $55,434 | $249 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 204 | $52,996 | $66 |
| Return visit (30+ min) | 79 | $15,188 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 117 | $13,941 | $106 |
See all 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 105 | $196,185 | $299 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 88 | $55,434 | $249 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 204 | $52,996 | $66 |
| Return visit (30+ min) | 79 | $15,188 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 117 | $13,941 | $106 |
| Dialysis services, 1 physician visit per month (20 years or older) | 30 | $7,877 | $171 |
| Short return visit (20+ min) | 49 | $5,147 | $71 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $4,694 | $41 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 17 | $4,484 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,577 | $143 |
| Return visit (30+ min) | 13 | $2,247 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,061 | $98 |
Who their Medicare patients are
430 Original Medicare patients in 2024. Average age 70 · Under 65 26% · 85 and older 15% · Women 47% · Also on Medicaid 66% · Health risk score 4.97. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 75% · Heart failure 54% · Coronary heart disease 46% · Atrial fibrillation 32% · COPD 28% · Depression 28% · Stroke 24% · Dementia 19% · Cancer 14%.
The office billed $900,350, Medicare allowed $487,071 and paid $386,757; for 3,741 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 430 | 3,741 | 70 | 4.97 | $900,350 | $386,757 |
| 2023 | 477 | 2,860 | 71 | 5.13 | $882,095 | $364,420 |
| 2022 | 406 | 2,860 | 69 | 5.39 | $933,565 | $393,944 |
| 2021 | 459 | 3,613 | 71 | 5.03 | $972,290 | $404,648 |
| 2020 | 472 | 3,949 | 71 | 5.62 | $978,235 | $356,842 |
| 2019 | 476 | 3,599 | 71 | 5.97 | $902,380 | $336,449 |
| 2018 | 445 | 3,067 | 71 | 5.52 | $725,445 | $263,626 |
| 2017 | 403 | 2,194 | 72 | 5.70 | $434,408 | $176,421 |
| 2016 | 454 | 2,155 | 72 | 5.82 | $325,391 | $166,321 |
| 2015 | 559 | 2,465 | 72 | 5.45 | $364,592 | $190,950 |
| 2014 | 546 | 2,503 | 72 | 5.13 | $345,265 | $179,985 |
| 2013 | 623 | 3,046 | 73 | 4.79 | $423,545 | $211,909 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 104 | $191,001 | $289 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 252 | $62,317 | $65 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 77 | $42,699 | $243 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 150 | $17,648 | $107 |
| Dialysis services, 1 physician visit per month (20 years or older) | 25 | $8,279 | $166 |
| Return visit (30+ min) | 52 | $7,927 | $91 |
| Short return visit (20+ min) | 69 | $5,549 | $57 |
| Return visit (30+ min) | 17 | $2,620 | $65 |
| Hemodialysis procedure with physician evaluation | 16 | $1,131 | $57 |
2022: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 120 | $214,419 | $299 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 104 | $60,170 | $245 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 184 | $51,284 | $59 |
| Home dialysis services per month (20 years or older) | 15 | $19,895 | $237 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 110 | $13,585 | $112 |
| Dialysis services, 1 physician visit per month (20 years or older) | 44 | $10,327 | $169 |
| Short return visit (20+ min) | 49 | $5,945 | $73 |
| Return visit (30+ min) | 31 | $5,260 | $105 |
| Dialysis services, per day, less than full month service (20 years or older) | 14 | $3,467 | $8 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,263 | $151 |
| Hemodialysis procedure with physician evaluation | 21 | $1,951 | $61 |
| Return visit (30+ min) | 14 | $1,521 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,059 | $81 |
2021: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 101 | $199,215 | $305 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 253 | $71,879 | $61 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 88 | $51,385 | $253 |
| Home dialysis services per month (20 years or older) | 12 | $24,557 | $243 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 144 | $18,405 | $115 |
| Dialysis services, 1 physician visit per month (20 years or older) | 29 | $8,912 | $175 |
| Short return visit (20+ min) | 53 | $7,787 | $68 |
| Dialysis services, per day, less than full month service (20 years or older) | 12 | $5,849 | $8 |
| Return visit (30+ min) | 17 | $2,874 | $82 |
| Return visit (30+ min) | 21 | $2,282 | $88 |
| Hemodialysis procedure with physician evaluation | 24 | $2,234 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,866 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,398 | $87 |
| New patient visit (45+ min) | 11 | $1,287 | $117 |
2020: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 98 | $156,798 | $245 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 276 | $87,061 | $63 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 90 | $41,643 | $206 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 168 | $23,491 | $117 |
| Dialysis services, 1 physician visit per month (20 years or older) | 37 | $8,689 | $158 |
| Return visit (30+ min) | 59 | $8,600 | $83 |
| Dialysis services, per day, less than full month service (20 years or older) | 15 | $5,301 | $7 |
| Hemodialysis procedure with physician evaluation | 27 | $2,816 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,437 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $1,719 | $86 |
| Short return visit (20+ min) | 21 | $1,449 | $60 |
2019: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 90 | $101,911 | $236 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 273 | $83,378 | $61 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 99 | $75,426 | $201 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 170 | $23,823 | $114 |
| Dialysis services, 1 physician visit per month (20 years or older) | 61 | $15,321 | $152 |
| Return visit (30+ min) | 68 | $10,651 | $81 |
| Hemodialysis procedure with physician evaluation | 35 | $3,045 | $61 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $2,760 | $6 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $2,590 | $86 |
2018: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 256 | $75,643 | $59 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 67 | $61,747 | $225 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 86 | $57,609 | $191 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 164 | $25,120 | $111 |
| Return visit (30+ min) | 70 | $12,046 | $80 |
| Dialysis services, 1 physician visit per month (20 years or older) | 43 | $11,304 | $149 |
| Hemodialysis procedure with physician evaluation | 29 | $3,321 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,957 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,788 | $85 |
2017: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 246 | $78,137 | $60 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 34 | $35,734 | $201 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 142 | $19,127 | $115 |
| Return visit (30+ min) | 78 | $14,210 | $85 |
| Dialysis services, 1 physician visit per month (20 years or older) | 26 | $9,506 | $156 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 14 | $4,215 | $234 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,326 | $166 |
| Hemodialysis procedure with physician evaluation | 27 | $2,835 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,509 | $87 |
| Short return visit (20+ min) | 20 | $1,128 | $47 |
2016: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 278 | $68,915 | $60 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $31,344 | $201 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 140 | $19,224 | $114 |
| Return visit (30+ min) | 78 | $12,810 | $83 |
| Dialysis services, 1 physician visit per month (20 years or older) | 27 | $7,637 | $156 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,014 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $3,370 | $82 |
| Short return visit (20+ min) | 44 | $3,319 | $56 |
| Hemodialysis procedure with physician evaluation | 34 | $3,208 | $61 |
| New patient visit (45+ min) | 12 | $1,520 | $127 |
| Blood glucose (sugar) level | 26 | $221 | $5 |
2015: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 381 | $78,959 | $60 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | $37,496 | $201 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 151 | $21,382 | $114 |
| Return visit (30+ min) | 82 | $17,649 | $84 |
| Dialysis services, 1 physician visit per month (20 years or older) | 26 | $6,183 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $6,089 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,861 | $168 |
| Hemodialysis procedure with physician evaluation | 38 | $4,150 | $61 |
| New patient visit (45+ min) | 13 | $1,665 | $128 |
| Short return visit (20+ min) | 17 | $1,152 | $58 |
| Hospital discharge day management, 30 minutes or less | 12 | $744 | $62 |
| Blood glucose (sugar) level | 18 | $190 | $5 |
2014: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 362 | $80,813 | $60 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 24 | $21,833 | $200 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 166 | $21,038 | $114 |
| Return visit (30+ min) | 85 | $12,840 | $83 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 13 | $5,790 | $232 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $5,671 | $153 |
| Long return visit (40+ min) | 33 | $5,162 | $117 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,735 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $4,229 | $86 |
| Hemodialysis procedure with physician evaluation | 42 | $4,009 | $61 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 15 | $2,607 | $77 |
| Short return visit (20+ min) | 22 | $1,620 | $58 |
| Hospital discharge day management, 30 minutes or less | 23 | $1,405 | $61 |
2013: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 411 | $88,879 | $58 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 28 | $23,573 | $236 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 172 | $22,806 | $111 |
| Return visit (30+ min) | 97 | $17,654 | $87 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $14,951 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $6,550 | $83 |
| Dialysis services, 1 physician visit per month (20 years or older) | 22 | $5,538 | $154 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $4,834 | $161 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 15 | $3,556 | $74 |
| Long return visit (40+ min) | 24 | $3,132 | $120 |
| Hemodialysis procedure with physician evaluation | 40 | $2,986 | $59 |
| New patient visit (45+ min) | 20 | $2,658 | $133 |
| Hospital discharge day management, 30 minutes or less | 37 | $2,135 | $56 |
| Short return visit (20+ min) | 31 | $1,984 | $57 |
| Blood glucose (sugar) level | 11 | $74 | $5 |
Medicaid work
$149,952 in 2024
Medicaid paid $149,952 for 2,032 billed services this clinician did in 2024, up to 86 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 721 | $98,730 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 249 | $24,773 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 910 | $20,752 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 121 | $4,966 |
| Return visit (30+ min) | 31 | $732 |
| 2024 | 2,032 | 5 | 86 | $149,952 |
| 2023 | 2,473 | 5 | 99 | $180,213 |
| 2022 | 2,172 | 7 | 84 | $153,558 |
| 2021 | 1,905 | 5 | 61 | $120,596 |
| 2020 | 1,831 | 4 | 50 | $114,040 |
| 2019 | 1,505 | 5 | 35 | $86,852 |
| 2018 | 1,324 | 4 | 32 | $60,136 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 955 | $119,420 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 255 | $30,095 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,103 | $24,251 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 148 | $6,231 |
| Short return visit (20+ min) | 12 | $217 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 801 | $94,221 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 295 | $31,100 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 965 | $23,451 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 58 | $3,082 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 16 | $1,153 |
| Short return visit (20+ min) | 25 | $279 |
| Return visit (30+ min) | 12 | $273 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 577 | $70,502 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,053 | $24,759 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 220 | $22,305 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 43 | $2,101 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 12 | $928 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 521 | $65,172 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,042 | $22,705 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 171 | $21,900 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 97 | $4,263 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 318 | $34,445 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 261 | $30,600 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 834 | $16,968 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 79 | $3,759 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 13 | $1,080 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 272 | $25,637 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 213 | $18,413 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 787 | $14,186 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 52 | $1,901 |
Drugs they prescribed that Part D paid
$824,358
Pharmacies billed $824,358 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
3,024 generic and 836 brand-name prescriptions · $824,358 in drug cost · 33 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 67 | $160,713 | $2,399 |
| Veltassa | 98 | $100,672 | $1,027 |
| Xphozah | 31 | $84,841 | $2,737 |
| Sevelamer | 129 | $66,053 | $512 |
| Auryxia | 46 | $65,119 | $1,416 |
See all 66 drugs
| Velphoro | 67 | $160,713 | $2,399 |
| Veltassa | 98 | $100,672 | $1,027 |
| Xphozah | 31 | $84,841 | $2,737 |
| Sevelamer | 129 | $66,053 | $512 |
| Auryxia | 46 | $65,119 | $1,416 |
| Rayaldee | 39 | $64,991 | $1,666 |
| Lokelma | 86 | $50,580 | $588 |
| Farxiga | 33 | $31,569 | $957 |
| Prosol | 173 | $29,113 | $168 |
| Omeprazole-Sodium Bicarbonate | 35 | $26,642 | $761 |
| Sevelamer Carbonate | 108 | $21,154 | $196 |
| Clinolipid | 86 | $20,409 | $237 |
| Januvia | 16 | $17,046 | $1,065 |
| Jardiance | 12 | $7,532 | $628 |
| Dexlansoprazole Dr | 35 | $6,321 | $181 |
| Calcium Acetate | 103 | $3,967 | $39 |
| Calcitriol | 120 | $2,897 | $24 |
| Alogliptin | 12 | $2,735 | $228 |
| Clonidine | 29 | $2,443 | $84 |
| Nifedipine Er | 123 | $2,348 | $19 |
| Hydralazine | 242 | $1,673 | $7 |
| Midodrine | 28 | $1,206 | $43 |
| Losartan | 170 | $1,032 | $6 |
| Minoxidil | 45 | $980 | $22 |
| Amlodipine Besylate | 252 | $954 | $4 |
| Metoprolol | 88 | $848 | $10 |
| Ultra-Fine Mini Pen Needle | 14 | $834 | $60 |
| Tamsulosin | 96 | $726 | $8 |
| Furosemide | 220 | $692 | $3 |
| Cinacalcet | 23 | $636 | $28 |
| Pantoprazole | 67 | $609 | $9 |
| Carvedilol | 97 | $563 | $6 |
| Labetalol | 22 | $510 | $23 |
| Tacrolimus | 12 | $469 | $39 |
| Atorvastatin | 123 | $460 | $4 |
| Lisinopril | 102 | $437 | $4 |
| Lactulose | 29 | $408 | $14 |
| Atenolol | 98 | $356 | $4 |
| Valsartan | 46 | $332 | $7 |
| Albuterol Sulfate Hfa | 12 | $305 | $25 |
| Metformin | 21 | $269 | $13 |
| Isosorbide Mononitrate Er | 22 | $266 | $12 |
| Potassium Chloride | 14 | $250 | $18 |
| Finasteride | 19 | $225 | $12 |
| Glipizide | 11 | $206 | $19 |
| Telmisartan | 14 | $191 | $14 |
| Rosuvastatin | 22 | $165 | $8 |
| Olmesartan Medoxomil | 16 | $161 | $10 |
| Hydrochlorothiazide | 50 | $157 | $3 |
| Gabapentin | 39 | $133 | $3 |
| Glipizide Er | 22 | $129 | $6 |
| Repaglinide | 22 | $120 | $5 |
| Glimepiride | 15 | $112 | $7 |
| Allopurinol | 34 | $109 | $3 |
| Clonidine | 36 | $107 | $3 |
| Prednisone | 23 | $84 | $4 |
| Sure Comfort Alcohol | 11 | $73 | $7 |
| Ondansetron | 13 | $62 | $5 |
| Levothyroxine | 11 | $58 | $5 |
| Clopidogrel | 11 | $55 | $5 |
| Metoprolol | 25 | $52 | $2 |
| Gemfibrozil | 13 | $46 | $4 |
| Escitalopram | 13 | $37 | $3 |
| Cephalexin | 11 | $36 | $3 |
| Levofloxacin | 13 | $26 | $2 |
| Benazepril | 11 | $16 | $1 |
Year by year
| 2024 | 3,909 | 295 | None | 21% | $824,358 |
| 2023 | 3,218 | 281 | None | 20% | $675,564 |
| 2022 | 2,217 | 274 | None | 18% | $429,123 |
| 2021 | 1,642 | 223 | None | 14% | $290,379 |
| 2020 | 1,773 | 219 | None | 16% | $442,377 |
| 2019 | 2,283 | 255 | 1% (16) | 16% | $396,090 |
| 2018 | 2,687 | 299 | 0% (11) | 15% | $431,082 |
| 2017 | 2,996 | 308 | 1% (18) | 25% | $557,347 |
| 2016 | 3,449 | 299 | 0% (11) | 23% | $478,657 |
| 2015 | 3,286 | 316 | 1% (20) | 24% | $458,426 |
| 2014 | 3,006 | 299 | 1% (39) | 27% | $391,546 |
| 2013 | 2,753 | 274 | 2% (61) | 31% | $298,348 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 51 drugs
| Auryxia | 91 | $146,898 | $1,614 |
| Velphoro | 40 | $122,069 | $3,052 |
| Veltassa | 113 | $114,467 | $1,013 |
| Sevelamer Carbonate | 138 | $35,071 | $254 |
| Lokelma | 59 | $33,130 | $562 |
| Renvela | 14 | $25,257 | $1,804 |
| Eliquis | 26 | $24,135 | $928 |
| Farxiga | 28 | $17,147 | $612 |
| Sevelamer | 29 | $15,435 | $532 |
| Cinacalcet | 20 | $14,151 | $708 |
| Rayaldee | 11 | $14,012 | $1,274 |
| Calcium Acetate | 106 | $7,497 | $71 |
| Prosol | 39 | $7,446 | $191 |
| Nifedipine Er | 115 | $6,475 | $56 |
| Calcitriol | 143 | $4,416 | $31 |
| Clonidine | 32 | $4,198 | $131 |
| Hydralazine | 160 | $2,659 | $17 |
| Tacrolimus | 15 | $2,337 | $156 |
| Labetalol | 51 | $2,083 | $41 |
| Losartan | 178 | $1,862 | $10 |
| Amlodipine Besylate | 237 | $1,756 | $7 |
| Lisinopril | 131 | $1,701 | $13 |
| Metoprolol | 75 | $1,389 | $19 |
| Carvedilol | 100 | $1,321 | $13 |
| Furosemide | 153 | $1,129 | $7 |
| Pantoprazole | 78 | $1,035 | $13 |
| Tamsulosin | 76 | $1,009 | $13 |
| Atorvastatin | 113 | $968 | $9 |
| Atenolol | 98 | $759 | $8 |
| Midodrine | 11 | $751 | $68 |
| Clonidine | 57 | $733 | $13 |
| Lactulose | 15 | $662 | $44 |
| Gabapentin | 51 | $608 | $12 |
| Valsartan | 24 | $550 | $23 |
| Minoxidil | 29 | $491 | $17 |
| Albuterol Sulfate Hfa | 11 | $449 | $41 |
| Isosorbide Mononitrate Er | 18 | $350 | $19 |
| Glipizide Er | 12 | $258 | $22 |
| Loperamide | 12 | $247 | $21 |
| Glimepiride | 16 | $235 | $15 |
| Olmesartan Medoxomil | 15 | $220 | $15 |
| Levothyroxine | 15 | $220 | $15 |
| Hydrochlorothiazide | 47 | $218 | $5 |
| Benazepril | 19 | $205 | $11 |
| Prednisone | 19 | $186 | $10 |
| Simvastatin | 15 | $155 | $10 |
| Metformin | 12 | $123 | $10 |
| Allopurinol | 14 | $100 | $7 |
| Gemfibrozil | 12 | $82 | $7 |
| Metoprolol | 14 | $76 | $5 |
| Clopidogrel | 11 | $65 | $6 |
2022: 44 drugs
| Auryxia | 44 | $108,639 | $2,469 |
| Sevelamer Carbonate | 135 | $60,767 | $450 |
| Veltassa | 32 | $35,837 | $1,120 |
| Velphoro | 16 | $30,947 | $1,934 |
| Renvela | 23 | $29,622 | $1,288 |
| Sevelamer | 26 | $22,625 | $870 |
| Lokelma | 22 | $17,237 | $783 |
| Januvia | 19 | $14,428 | $759 |
| Cinacalcet | 25 | $13,405 | $536 |
| Farxiga | 21 | $12,984 | $618 |
| Calcium Acetate | 114 | $11,847 | $104 |
| Tacrolimus | 16 | $6,146 | $384 |
| Clonidine | 21 | $4,532 | $216 |
| Calcitriol | 131 | $3,392 | $26 |
| Nifedipine Er | 55 | $2,897 | $53 |
| Losartan | 112 | $1,119 | $10 |
| Labetalol | 21 | $960 | $46 |
| Hydralazine | 83 | $939 | $11 |
| Valsartan | 15 | $849 | $57 |
| Lisinopril | 105 | $837 | $8 |
| Tamsulosin | 53 | $818 | $15 |
| Carvedilol | 95 | $775 | $8 |
| Atenolol | 93 | $673 | $7 |
| Amlodipine Besylate | 111 | $664 | $6 |
| Olmesartan Medoxomil | 11 | $650 | $59 |
| Atorvastatin | 80 | $619 | $8 |
| Furosemide | 116 | $562 | $5 |
| Pantoprazole | 45 | $459 | $10 |
| Metoprolol | 19 | $393 | $21 |
| Levothyroxine | 20 | $329 | $16 |
| Clonidine | 16 | $261 | $16 |
| Prednisone | 34 | $252 | $7 |
| Hydrochlorothiazide | 59 | $244 | $4 |
| Minoxidil | 11 | $241 | $22 |
| Glipizide Er | 11 | $229 | $21 |
| Finasteride | 11 | $206 | $19 |
| Repaglinide | 13 | $196 | $15 |
| Gabapentin | 19 | $191 | $10 |
| Metformin | 25 | $158 | $6 |
| Allopurinol | 15 | $128 | $9 |
| Trazodone | 12 | $86 | $7 |
| Metoprolol | 16 | $41 | $3 |
| Gemfibrozil | 12 | $32 | $3 |
| Famotidine | 11 | $24 | $2 |
2021: 35 drugs
| Veltassa | 33 | $44,923 | $1,361 |
| Renvela | 14 | $38,767 | $2,769 |
| Sevelamer Carbonate | 96 | $35,350 | $368 |
| Januvia | 29 | $19,300 | $666 |
| Farxiga | 11 | $7,016 | $638 |
| Calcium Acetate | 58 | $5,342 | $92 |
| Tacrolimus | 12 | $3,565 | $297 |
| Calcitriol | 110 | $3,338 | $30 |
| Clinisol | 34 | $3,245 | $95 |
| Cinacalcet | 12 | $3,231 | $269 |
| Insulin Lispro | 11 | $1,621 | $147 |
| Nifedipine Er | 26 | $1,075 | $41 |
| Valsartan | 13 | $881 | $68 |
| Losartan | 88 | $864 | $10 |
| Tamsulosin | 66 | $822 | $12 |
| Carvedilol | 90 | $633 | $7 |
| Albuterol Sulfate Hfa | 18 | $604 | $34 |
| Amlodipine Besylate | 120 | $543 | $5 |
| Hydralazine | 45 | $538 | $12 |
| Furosemide | 74 | $447 | $6 |
| Atenolol | 54 | $431 | $8 |
| Metoprolol | 22 | $430 | $20 |
| Lisinopril | 63 | $403 | $6 |
| Minoxidil | 17 | $382 | $22 |
| Pantoprazole | 35 | $316 | $9 |
| Finasteride | 12 | $309 | $26 |
| Atorvastatin | 43 | $253 | $6 |
| Repaglinide | 15 | $231 | $15 |
| Hydrochlorothiazide | 39 | $211 | $5 |
| Gabapentin | 16 | $135 | $8 |
| Clonidine | 15 | $127 | $8 |
| Glipizide Er | 12 | $86 | $7 |
| Prednisone | 15 | $76 | $5 |
| Metoprolol | 12 | $56 | $5 |
| Gemfibrozil | 12 | $32 | $3 |
2020: 39 drugs
| Renvela | 21 | $80,286 | $3,823 |
| Veltassa | 20 | $26,155 | $1,308 |
| Sevelamer Carbonate | 74 | $24,596 | $332 |
| Januvia | 15 | $19,137 | $1,276 |
| Dexilant | 23 | $8,551 | $372 |
| Novolog Flexpen | 11 | $8,078 | $734 |
| Cinacalcet | 12 | $7,189 | $599 |
| Eliquis | 14 | $6,921 | $494 |
| Calcitriol | 110 | $4,143 | $38 |
| Calcium Acetate | 45 | $3,048 | $68 |
| Valganciclovir | 24 | $2,712 | $113 |
| Clonidine | 15 | $2,702 | $180 |
| Nifedipine Er | 38 | $2,549 | $67 |
| Valsartan | 31 | $1,451 | $47 |
| Clinisol | 15 | $1,238 | $83 |
| Hydralazine | 85 | $1,133 | $13 |
| Easy Comfort Pen Needles | 13 | $1,109 | $85 |
| Amlodipine Besylate | 159 | $936 | $6 |
| Losartan | 79 | $652 | $8 |
| Furosemide | 103 | $652 | $6 |
| Tamsulosin | 46 | $629 | $14 |
| Atenolol | 66 | $561 | $8 |
| Lisinopril | 58 | $511 | $9 |
| Carvedilol | 77 | $480 | $6 |
| Hydrochlorothiazide | 50 | $303 | $6 |
| Atorvastatin | 53 | $294 | $6 |
| Levothyroxine | 12 | $293 | $24 |
| Metoprolol | 17 | $280 | $16 |
| Pantoprazole | 35 | $247 | $7 |
| Glipizide | 31 | $222 | $7 |
| Clonidine | 18 | $185 | $10 |
| Omeprazole | 13 | $145 | $11 |
| Gabapentin | 15 | $120 | $8 |
| Glipizide Er | 16 | $109 | $7 |
| Metoprolol | 15 | $89 | $6 |
| Sulfamethoxazole-Trimethoprim | 14 | $69 | $5 |
| Citalopram Hbr | 12 | $51 | $4 |
| Gemfibrozil | 12 | $47 | $4 |
| Prednisone | 13 | $41 | $3 |
2019: 47 drugs
| Velphoro | 29 | $72,857 | $2,512 |
| Renvela | 27 | $72,342 | $2,679 |
| Sevelamer Carbonate | 93 | $30,290 | $326 |
| Januvia | 32 | $24,878 | $777 |
| Veltassa | 20 | $20,285 | $1,014 |
| Sensipar | 11 | $16,736 | $1,521 |
| Eliquis | 22 | $10,823 | $492 |
| Dexilant | 21 | $7,291 | $347 |
| Calcium Acetate | 102 | $6,764 | $66 |
| Clonidine | 31 | $5,730 | $185 |
| Calcitriol | 158 | $5,547 | $35 |
| Nifedipine Er | 73 | $4,927 | $67 |
| Valganciclovir | 18 | $3,524 | $196 |
| Potassium Chloride | 16 | $2,641 | $165 |
| Hydralazine | 130 | $2,124 | $16 |
| Easy Comfort Pen Needles | 15 | $1,227 | $82 |
| Amlodipine Besylate | 154 | $1,194 | $8 |
| Losartan | 121 | $1,114 | $9 |
| Tacrolimus | 12 | $934 | $78 |
| Ventolin Hfa | 11 | $786 | $71 |
| Atorvastatin | 74 | $671 | $9 |
| Rosuvastatin | 14 | $646 | $46 |
| Carvedilol | 60 | $630 | $10 |
| Furosemide | 112 | $623 | $6 |
| Atenolol | 77 | $504 | $7 |
| Tamsulosin | 24 | $481 | $20 |
| Metoprolol | 13 | $472 | $36 |
| Temazepam | 20 | $467 | $23 |
| Lisinopril | 59 | $436 | $7 |
| Finasteride | 14 | $420 | $30 |
| Amoxicillin-Clavulanate Potass | 19 | $356 | $19 |
| Pantoprazole | 43 | $326 | $8 |
| Clonidine | 25 | $317 | $13 |
| Levothyroxine | 22 | $315 | $14 |
| Gabapentin | 24 | $297 | $12 |
| Glipizide | 37 | $246 | $7 |
| Metoprolol | 51 | $232 | $5 |
| Omeprazole | 21 | $205 | $10 |
| Glipizide Er | 12 | $184 | $15 |
| Allopurinol | 11 | $180 | $16 |
| Benazepril | 13 | $160 | $12 |
| Simvastatin | 13 | $97 | $7 |
| Prednisone | 16 | $89 | $6 |
| Levofloxacin | 11 | $82 | $7 |
| Hydrochlorothiazide | 16 | $74 | $5 |
| Gemfibrozil | 11 | $61 | $6 |
| Citalopram Hbr | 16 | $59 | $4 |
2018: 48 drugs
| Renvela | 68 | $104,621 | $1,539 |
| Sevelamer Carbonate | 93 | $72,325 | $778 |
| Velphoro | 17 | $37,623 | $2,213 |
| Sensipar | 27 | $34,535 | $1,279 |
| Auryxia | 12 | $24,594 | $2,049 |
| Veltassa | 21 | $20,709 | $986 |
| Januvia | 19 | $13,479 | $709 |
| Calcium Acetate | 180 | $13,292 | $74 |
| Calcitriol | 149 | $5,449 | $37 |
| Nifedipine Er | 88 | $4,545 | $52 |
| Dexilant | 12 | $4,457 | $371 |
| Clonidine | 39 | $4,277 | $110 |
| Potassium Chloride | 30 | $3,679 | $123 |
| Nateglinide | 11 | $1,340 | $122 |
| Lansoprazole | 19 | $1,338 | $70 |
| Amlodipine Besylate | 144 | $1,246 | $9 |
| Losartan | 146 | $1,229 | $8 |
| Hydralazine | 98 | $1,137 | $12 |
| Midodrine | 23 | $1,058 | $46 |
| Labetalol | 22 | $919 | $42 |
| Furosemide | 166 | $813 | $5 |
| Metoprolol | 20 | $748 | $37 |
| Valsartan | 29 | $710 | $24 |
| Tamsulosin | 27 | $708 | $26 |
| Carvedilol | 111 | $706 | $6 |
| Lisinopril | 75 | $547 | $7 |
| Atorvastatin | 59 | $543 | $9 |
| Temazepam | 19 | $514 | $27 |
| Pantoprazole | 66 | $486 | $7 |
| Atenolol | 99 | $470 | $5 |
| Gabapentin | 30 | $416 | $14 |
| Metoprolol | 81 | $349 | $4 |
| Finasteride | 14 | $285 | $20 |
| Diphenoxylate-Atropine | 15 | $273 | $18 |
| Clonidine | 42 | $269 | $6 |
| Omeprazole | 27 | $233 | $9 |
| Levothyroxine | 21 | $180 | $9 |
| Glipizide | 32 | $170 | $5 |
| Prednisone | 28 | $158 | $6 |
| Clopidogrel | 19 | $152 | $8 |
| Levofloxacin | 16 | $134 | $8 |
| Simvastatin | 27 | $133 | $5 |
| Hydrochlorothiazide | 22 | $103 | $5 |
| Amoxicillin-Clavulanate Potass | 12 | $101 | $8 |
| Hydrocortisone | 13 | $62 | $5 |
| Enalapril Maleate | 11 | $58 | $5 |
| Gemfibrozil | 12 | $40 | $3 |
| Citalopram Hbr | 13 | $30 | $2 |
2017: 52 drugs
| Sensipar | 149 | $179,647 | $1,206 |
| Renvela | 164 | $172,059 | $1,049 |
| Velphoro | 12 | $27,587 | $2,299 |
| Januvia | 53 | $23,840 | $450 |
| Sevelamer Carbonate | 12 | $13,019 | $1,085 |
| Calcium Acetate | 153 | $11,469 | $75 |
| Lantus Solostar | 20 | $6,699 | $335 |
| Calcitriol | 169 | $6,010 | $36 |
| Dexilant | 16 | $5,542 | $346 |
| Prosol | 34 | $4,073 | $120 |
| Coreg Cr | 13 | $3,638 | $280 |
| Clonidine | 18 | $2,244 | $125 |
| Potassium Chloride | 20 | $2,093 | $105 |
| Nateglinide | 22 | $1,885 | $86 |
| Humulin 70-30 | 13 | $1,868 | $144 |
| Losartan | 194 | $1,573 | $8 |
| Nifedipine Er | 51 | $1,564 | $31 |
| Niacin Er | 11 | $1,462 | $133 |
| Valsartan | 41 | $1,122 | $27 |
| Tamsulosin | 33 | $1,091 | $33 |
| Amlodipine Besylate | 181 | $1,022 | $6 |
| Carvedilol | 140 | $892 | $6 |
| Hydralazine | 78 | $881 | $11 |
| Pantoprazole | 92 | $827 | $9 |
| Lisinopril | 113 | $726 | $6 |
| Labetalol | 12 | $687 | $57 |
| Gabapentin | 58 | $654 | $11 |
| Furosemide | 140 | $637 | $5 |
| Atorvastatin | 58 | $584 | $10 |
| Metoprolol | 28 | $574 | $21 |
| Enalapril Maleate | 25 | $534 | $21 |
| Atenolol | 89 | $524 | $6 |
| Midodrine | 27 | $476 | $18 |
| Finasteride | 20 | $407 | $20 |
| Temazepam | 19 | $386 | $20 |
| Repaglinide | 12 | $355 | $30 |
| Metoprolol | 77 | $349 | $5 |
| Clonidine | 36 | $294 | $8 |
| Minoxidil | 12 | $265 | $22 |
| Omeprazole | 27 | $250 | $9 |
| Lansoprazole | 18 | $233 | $13 |
| Clopidogrel | 23 | $206 | $9 |
| Allopurinol | 14 | $169 | $12 |
| Simvastatin | 38 | $154 | $4 |
| Levofloxacin | 17 | $146 | $9 |
| Hydrochlorothiazide | 35 | $131 | $4 |
| Amoxicillin-Clavulanate Potass | 16 | $118 | $7 |
| Glipizide | 20 | $94 | $5 |
| Prednisone | 13 | $82 | $6 |
| Levothyroxine | 12 | $53 | $4 |
| Escitalopram | 13 | $53 | $4 |
| Metoclopramide | 11 | $45 | $4 |
2016: 55 drugs
| Renvela | 140 | $160,901 | $1,149 |
| Sensipar | 92 | $99,878 | $1,086 |
| Renagel | 24 | $41,544 | $1,731 |
| Calcium Acetate | 238 | $17,199 | $72 |
| Januvia | 44 | $16,953 | $385 |
| Prosol | 65 | $10,727 | $165 |
| Onglyza | 12 | $7,739 | $645 |
| Dexilant | 26 | $7,507 | $289 |
| Intralipid | 16 | $6,015 | $376 |
| Calcitriol | 165 | $5,556 | $34 |
| Tradjenta | 12 | $4,281 | $357 |
| Paricalcitol | 11 | $2,751 | $250 |
| Humulin 70-30 | 17 | $2,260 | $133 |
| Eliquis | 11 | $2,204 | $200 |
| Nifedipine Er | 65 | $2,092 | $32 |
| Losartan | 238 | $1,989 | $8 |
| Niacin Er | 18 | $1,645 | $91 |
| Repaglinide | 20 | $1,610 | $80 |
| Tamsulosin | 50 | $1,352 | $27 |
| Hydralazine | 105 | $1,265 | $12 |
| Pantoprazole | 128 | $1,243 | $10 |
| Carvedilol | 165 | $1,182 | $7 |
| Lisinopril | 182 | $1,093 | $6 |
| Amlodipine Besylate | 183 | $994 | $5 |
| Valsartan | 44 | $937 | $21 |
| Furosemide | 144 | $714 | $5 |
| Enalapril Maleate | 25 | $712 | $28 |
| Nateglinide | 12 | $698 | $58 |
| Metoprolol | 103 | $571 | $6 |
| Atorvastatin | 56 | $556 | $10 |
| Metoprolol | 29 | $542 | $19 |
| Allopurinol | 32 | $471 | $15 |
| Gabapentin | 51 | $451 | $9 |
| Pen Needle | 16 | $436 | $27 |
| Atenolol | 99 | $435 | $4 |
| Finasteride | 29 | $423 | $15 |
| Temazepam | 25 | $412 | $16 |
| Metolazone | 12 | $406 | $34 |
| Labetalol | 17 | $355 | $21 |
| Clonidine | 51 | $350 | $7 |
| Lansoprazole | 14 | $342 | $24 |
| Terazosin | 19 | $283 | $15 |
| Clopidogrel | 25 | $262 | $10 |
| Omeprazole | 41 | $232 | $6 |
| Levofloxacin | 17 | $213 | $13 |
| Metoclopramide | 20 | $183 | $9 |
| Hydrochlorothiazide | 47 | $181 | $4 |
| Glipizide | 34 | $169 | $5 |
| Metformin | 19 | $156 | $8 |
| Simvastatin | 27 | $154 | $6 |
| Sertraline | 13 | $130 | $10 |
| Glimepiride | 15 | $128 | $9 |
| Levothyroxine | 16 | $88 | $5 |
| Escitalopram | 16 | $88 | $5 |
| Prednisone | 14 | $72 | $5 |
2015: 59 drugs
| Renvela | 198 | $226,378 | $1,143 |
| Sensipar | 103 | $83,390 | $810 |
| Renagel | 18 | $21,883 | $1,216 |
| Calcium Acetate | 165 | $12,697 | $77 |
| Januvia | 35 | $12,128 | $347 |
| Procrit | 12 | $8,787 | $732 |
| Tradjenta | 16 | $5,980 | $374 |
| Dexilant | 16 | $4,274 | $267 |
| Niacin Er | 15 | $3,368 | $225 |
| Calcitriol | 134 | $2,859 | $21 |
| Coreg Cr | 11 | $2,379 | $216 |
| Lisinopril | 287 | $1,788 | $6 |
| Humulin 70-30 | 15 | $1,763 | $118 |
| Valsartan | 28 | $1,718 | $61 |
| Losartan | 237 | $1,715 | $7 |
| Nifedipine Er | 37 | $1,542 | $42 |
| Tamsulosin | 38 | $1,357 | $36 |
| Nateglinide | 14 | $1,032 | $74 |
| Carvedilol | 150 | $907 | $6 |
| Amlodipine Besylate | 212 | $893 | $4 |
| Hydroxychloroquine Sulfate | 11 | $890 | $81 |
| Labetalol | 22 | $875 | $40 |
| Enalapril Maleate | 23 | $642 | $28 |
| Furosemide | 153 | $600 | $4 |
| Pantoprazole | 60 | $585 | $10 |
| Metoprolol | 27 | $580 | $21 |
| Gabapentin | 62 | $550 | $9 |
| Metoprolol | 94 | $521 | $6 |
| Hydralazine | 41 | $471 | $11 |
| Lansoprazole | 17 | $462 | $27 |
| Allopurinol | 29 | $430 | $15 |
| Atorvastatin | 49 | $417 | $9 |
| Atenolol | 88 | $375 | $4 |
| Simvastatin | 44 | $332 | $8 |
| Clonidine | 51 | $320 | $6 |
| Metolazone | 12 | $317 | $26 |
| Nifedical Xl | 11 | $310 | $28 |
| Omeprazole | 45 | $279 | $6 |
| Gentamicin Sulfate | 11 | $275 | $25 |
| Finasteride | 22 | $253 | $12 |
| Hydrochlorothiazide | 45 | $249 | $6 |
| Clopidogrel | 26 | $238 | $9 |
| Amoxicillin-Clavulanate Potass | 14 | $231 | $16 |
| Afeditab Cr | 13 | $218 | $17 |
| Levothyroxine | 18 | $207 | $11 |
| Glipizide | 34 | $166 | $5 |
| Terazosin | 20 | $160 | $8 |
| Insulin | 11 | $139 | $13 |
| Prednisone | 19 | $129 | $7 |
| Buspirone | 12 | $122 | $10 |
| Levofloxacin | 17 | $120 | $7 |
| Alprazolam | 25 | $109 | $4 |
| Benazepril | 25 | $88 | $4 |
| Escitalopram | 12 | $87 | $7 |
| Metformin | 18 | $79 | $4 |
| Sertraline | 18 | $76 | $4 |
| Temazepam | 14 | $70 | $5 |
| Famotidine | 11 | $53 | $5 |
| Diazepam | 12 | $30 | $2 |
2014: 53 drugs
| Renvela | 154 | $152,652 | $991 |
| Sensipar | 97 | $73,261 | $755 |
| Sevelamer Carbonate | 23 | $16,929 | $736 |
| Fosrenol | 13 | $14,523 | $1,117 |
| Calcium Acetate | 121 | $14,307 | $118 |
| Diovan | 62 | $14,295 | $231 |
| Januvia | 46 | $14,273 | $310 |
| Dexilant | 20 | $3,699 | $185 |
| Repaglinide | 15 | $3,642 | $243 |
| Janumet | 12 | $3,581 | $298 |
| Paricalcitol | 12 | $3,555 | $296 |
| Valsartan | 17 | $2,867 | $169 |
| Calcitriol | 120 | $2,632 | $22 |
| Colcrys | 14 | $2,307 | $165 |
| Nifedipine Er | 51 | $2,030 | $40 |
| Lisinopril | 242 | $1,562 | $6 |
| Losartan | 127 | $1,550 | $12 |
| Carvedilol | 177 | $1,449 | $8 |
| Nifedical Xl | 19 | $963 | $51 |
| Amlodipine Besylate | 159 | $885 | $6 |
| Hydralazine | 45 | $863 | $19 |
| Tamsulosin | 38 | $792 | $21 |
| Omeprazole | 65 | $767 | $12 |
| Metoprolol | 15 | $731 | $49 |
| Clopidogrel | 37 | $691 | $19 |
| Furosemide | 134 | $666 | $5 |
| Gabapentin | 73 | $654 | $9 |
| Pantoprazole | 45 | $570 | $13 |
| Metoprolol | 86 | $541 | $6 |
| Temazepam | 25 | $498 | $20 |
| Simvastatin | 63 | $475 | $8 |
| Atenolol | 72 | $444 | $6 |
| Labetalol | 14 | $381 | $27 |
| Atorvastatin | 28 | $337 | $12 |
| Metolazone | 17 | $329 | $19 |
| Hydrocodone-Acetaminophen | 20 | $319 | $16 |
| Enalapril Maleate | 14 | $275 | $20 |
| Glipizide | 20 | $246 | $12 |
| Terazosin | 25 | $212 | $8 |
| Clonidine | 27 | $204 | $8 |
| Allopurinol | 27 | $199 | $7 |
| Hydrochlorothiazide | 41 | $197 | $5 |
| Levofloxacin | 16 | $187 | $12 |
| Escitalopram | 15 | $186 | $12 |
| Glimepiride | 11 | $169 | $15 |
| Finasteride | 16 | $166 | $10 |
| Prednisone | 18 | $157 | $9 |
| Levothyroxine | 16 | $114 | $7 |
| Tramadol | 19 | $113 | $6 |
| Benazepril | 17 | $103 | $6 |
| Zolpidem | 13 | $101 | $8 |
| Famotidine | 16 | $90 | $6 |
| Lovastatin | 12 | $44 | $4 |
2013: 56 drugs
| Renvela | 155 | $108,424 | $700 |
| Sensipar | 41 | $30,217 | $737 |
| Diovan | 127 | $23,172 | $182 |
| Januvia | 58 | $17,598 | $303 |
| Calcium Acetate | 68 | $7,929 | $117 |
| Zemplar | 13 | $5,828 | $448 |
| Prosol | 35 | $5,585 | $160 |
| Calcitriol | 140 | $4,950 | $35 |
| Prandin | 14 | $4,475 | $320 |
| Janumet | 12 | $3,106 | $259 |
| Dexilant | 16 | $2,557 | $160 |
| Colcrys | 13 | $2,451 | $189 |
| Clonidine | 18 | $2,317 | $129 |
| Nifedipine Er | 24 | $1,899 | $79 |
| Hydralazine | 63 | $1,631 | $26 |
| Clopidogrel | 36 | $1,527 | $42 |
| Carvedilol | 162 | $1,522 | $9 |
| Nateglinide | 14 | $1,491 | $107 |
| Losartan | 65 | $1,313 | $20 |
| Lisinopril | 210 | $1,221 | $6 |
| Nifedical Xl | 25 | $1,169 | $47 |
| Levemir Flexpen | 11 | $1,137 | $103 |
| Amlodipine Besylate | 154 | $1,066 | $7 |
| Hydrocodone-Acetaminophen | 53 | $987 | $19 |
| Omeprazole | 55 | $985 | $18 |
| Atorvastatin | 36 | $858 | $24 |
| Tamsulosin | 42 | $827 | $20 |
| Pantoprazole | 50 | $780 | $16 |
| Metoprolol | 13 | $708 | $54 |
| Lansoprazole | 12 | $701 | $58 |
| Gabapentin | 66 | $693 | $11 |
| Furosemide | 108 | $514 | $5 |
| Metoprolol | 75 | $494 | $7 |
| Labetalol | 14 | $426 | $30 |
| Ketoconazole | 11 | $396 | $36 |
| Atenolol | 43 | $392 | $9 |
| Simvastatin | 33 | $338 | $10 |
| Clonidine | 29 | $300 | $10 |
| Terazosin | 29 | $280 | $10 |
| Glipizide | 16 | $242 | $15 |
| Glimepiride | 20 | $237 | $12 |
| Enalapril Maleate | 16 | $228 | $14 |
| Levothyroxine | 20 | $194 | $10 |
| Zolpidem | 22 | $187 | $8 |
| Escitalopram | 12 | $181 | $15 |
| Levofloxacin | 14 | $165 | $12 |
| Finasteride | 16 | $165 | $10 |
| Metolazone | 12 | $139 | $12 |
| Warfarin | 18 | $126 | $7 |
| Benazepril | 17 | $125 | $7 |
| Temazepam | 22 | $116 | $5 |
| Prednisone | 18 | $106 | $6 |
| Allopurinol | 21 | $105 | $5 |
| Hydrochlorothiazide | 17 | $82 | $5 |
| Lorazepam | 13 | $81 | $6 |
| Alprazolam | 15 | $59 | $4 |
Money from drug and device companies
$688 in 2025
| 2025 | 8 | 25 | None | $688 |
| 2024 | 8 | 15 | None | $504 |
| 2023 | 9 | 41 | $6,350 | $7,373 |
| 2022 | 7 | 40 | $16,300 | $18,099 |
| 2021 | 3 | 7 | $850 | $939 |
| 2020 | 3 | 4 | None | $79 |
| 2019 | 7 | 13 | None | $298 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $296 | 3 payments
|
| Akebia Therapeutics | Vafseo | $148 | 3 payments
|
| Amgen | Krystexxa | $91 | 4 payments
|
| Novo Nordisk | Rybelsus | $60 | 3 payments
|
| CorMedix | None | $30 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $27 | 1 payment
|
See all 17 published payments
| Akebia Therapeutics | Meals · 2025-12-08 | Vafseo | $127 |
| OPKO Pharmaceuticals | Meals · 2025-10-20 | Rayaldee | $20 |
| Novo Nordisk | Meals · 2025-10-15 | Rybelsus | $23 |
| Amgen | Meals · 2025-10-02 | Krystexxa | $23 |
| CorMedix | Meals · 2025-09-24 | None | $30 |
| Amgen | Meals · 2025-09-23 | Krystexxa | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-16 | Airsupra | $123 |
| Akebia Therapeutics | Meals · 2025-09-11 | Auryxia | $18 |
| Novo Nordisk | Meals · 2025-09-09 | Rybelsus | $19 |
| Amgen | Meals · 2025-08-18 | Krystexxa | $23 |
| Amgen | Meals · 2025-07-15 | Krystexxa | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-10 | Airsupra | $121 |
| Akebia Therapeutics | Meals · 2025-05-22 | Auryxia | $4 |
| Novo Nordisk | Meals · 2025-03-04 | Ozempic | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-02-03 | Jynarque | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-22 | Farxiga | $52 |
| Fresenius USA Marketing | Meals · 2025-01-21 | Velphoro | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $504
| Novartis Pharmaceuticals | Fabhalta | $157 | 3 payments
|
| Amgen | Krystexxa | $141 | 6 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $67 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $50 | 1 payment
|
| CorMedix | Defencath | $25 | 1 payment
|
| Novo Nordisk | Ozempic | $23 | 1 payment
|
| Ardelyx | Ibsrela | $22 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $20 | 1 payment
|
2023: $7,373
| AstraZeneca Pharmaceuticals LP | Farxiga | $7,098 | 18 payments
|
| Lilly USA | Mounjaro | $67 | 2 payments
|
| OPKO Pharmaceuticals | Rayaldee | $57 | 3 payments
|
| Calliditas Therapeutics US | Tarpeyo | $42 | 2 payments
|
| Fresenius USA Marketing | None | $41 | 2 payments
|
| Otsuka America Pharmaceutical | Jynarque | $23 | 1 payment
|
| Akebia Therapeutics | Auryxia | $17 | 1 payment
|
| Vifor Pharma | Veltassa | $15 | 1 payment
|
| GlaxoSmithKline | Benlysta | $14 | 1 payment
|
2022: $18,099
| AstraZeneca Pharmaceuticals LP | Farxiga | $17,863 | 34 payments
|
| Aurinia Pharma U.S. | Lupkynis | $125 | 1 payment
|
| GlaxoSmithKline | Benlysta | $34 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $30 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $17 | 1 payment
|
| Calliditas Therapeutics US | Tarpeyo | $16 | 1 payment
|
| Akebia Therapeutics | Auryxia | $14 | 1 payment
|
2021: $939
| AstraZeneca Pharmaceuticals LP | Farxiga | $871 | 4 payments
|
| Vifor Pharma | Veltassa | $47 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $21 | 1 payment
|
2020: $79
| AstraZeneca Pharmaceuticals LP | Lokelma | $37 | 2 payments
|
| Relypsa | Veltassa | $24 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $18 | 1 payment
|
2019: $298
| AstraZeneca Pharmaceuticals LP | Lokelma | $74 | 4 payments
|
| Amgen | Aranesp | $53 | 2 payments
|
| Akebia Therapeutics | Auryxia | $52 | 2 payments
|
| Otsuka America Pharmaceutical | Jynarque | $47 | 1 payment
|
| Relypsa | Veltassa | $41 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $19 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $12 | 1 payment
|
Professional record
- NPI
- 1689680654
- Licence
- CA A74264California A74264: Current · expires 2028-07-31
- Trained
- Irvine California College of Medicine, 2004 · 22 years ago
- Group
- California Kidney Specialists · Cua, Gan and Bien Medical Corporation · Cua and Gan Medical Corporation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 1335 W Cypress Ave, Suite # 205, San Dimas, CA, 91773
- NPI first listed
- 2006-07-31
- NPI last updated
- 2012-03-16
This is when the NPI record was last certified, not a medical board exam.